nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—Carboplatin—uterine cancer	0.171	0.215	CbGbCtD
Ticlopidine—CYP1A1—Progesterone—uterine cancer	0.0937	0.118	CbGbCtD
Ticlopidine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0816	0.102	CbGbCtD
Ticlopidine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0569	0.0715	CbGbCtD
Ticlopidine—CYP2C8—Progesterone—uterine cancer	0.0541	0.0679	CbGbCtD
Ticlopidine—CYP2C19—Progesterone—uterine cancer	0.0453	0.057	CbGbCtD
Ticlopidine—CYP1A2—Progesterone—uterine cancer	0.0418	0.0526	CbGbCtD
Ticlopidine—CYP2C9—Progesterone—uterine cancer	0.0377	0.0474	CbGbCtD
Ticlopidine—CYP2D6—Progesterone—uterine cancer	0.0345	0.0433	CbGbCtD
Ticlopidine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0331	0.0416	CbGbCtD
Ticlopidine—CYP2E1—Etoposide—uterine cancer	0.0324	0.0407	CbGbCtD
Ticlopidine—CYP2C8—Etoposide—uterine cancer	0.0242	0.0304	CbGbCtD
Ticlopidine—CYP3A4—Progesterone—uterine cancer	0.0219	0.0275	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—uterine cancer	0.0218	0.0274	CbGbCtD
Ticlopidine—CYP1A2—Etoposide—uterine cancer	0.0187	0.0235	CbGbCtD
Ticlopidine—CYP2D6—Doxorubicin—uterine cancer	0.0105	0.0132	CbGbCtD
Ticlopidine—CYP3A4—Etoposide—uterine cancer	0.00981	0.0123	CbGbCtD
Ticlopidine—P2RY12—artery—uterine cancer	0.00726	0.25	CbGeAlD
Ticlopidine—CYP3A4—Doxorubicin—uterine cancer	0.00669	0.0084	CbGbCtD
Ticlopidine—Nephrotic syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00353	0.0253	CcSEcCtD
Ticlopidine—Hepatic necrosis—Progesterone—uterine cancer	0.00324	0.0233	CcSEcCtD
Ticlopidine—MPO—artery—uterine cancer	0.00318	0.11	CbGeAlD
Ticlopidine—P2RY12—epithelium—uterine cancer	0.00275	0.0949	CbGeAlD
Ticlopidine—Nephritis interstitial—Medroxyprogesterone Acetate—uterine cancer	0.00253	0.0181	CcSEcCtD
Ticlopidine—Tubulointerstitial nephritis—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.016	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Progesterone—uterine cancer	0.00214	0.0154	CcSEcCtD
Ticlopidine—Diarrhoea haemorrhagic—Epirubicin—uterine cancer	0.00214	0.0153	CcSEcCtD
Ticlopidine—Nephropathy—Etoposide—uterine cancer	0.00202	0.0145	CcSEcCtD
Ticlopidine—Leukaemia—Epirubicin—uterine cancer	0.002	0.0144	CcSEcCtD
Ticlopidine—Diarrhoea haemorrhagic—Doxorubicin—uterine cancer	0.00198	0.0142	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.0139	CcSEcCtD
Ticlopidine—Leukaemia—Doxorubicin—uterine cancer	0.00185	0.0133	CcSEcCtD
Ticlopidine—Vascular purpura—Progesterone—uterine cancer	0.00153	0.011	CcSEcCtD
Ticlopidine—Hepatic failure—Progesterone—uterine cancer	0.00152	0.0109	CcSEcCtD
Ticlopidine—Sepsis—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0106	CcSEcCtD
Ticlopidine—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.0102	CcSEcCtD
Ticlopidine—Purpura—Progesterone—uterine cancer	0.00142	0.0102	CcSEcCtD
Ticlopidine—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00989	CcSEcCtD
Ticlopidine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00985	CcSEcCtD
Ticlopidine—Osteoarthritis—Progesterone—uterine cancer	0.00137	0.00981	CcSEcCtD
Ticlopidine—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00923	CcSEcCtD
Ticlopidine—Liver function test abnormal—Progesterone—uterine cancer	0.00126	0.00906	CcSEcCtD
Ticlopidine—Osteoarthritis—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00889	CcSEcCtD
Ticlopidine—Cramp muscle—Progesterone—uterine cancer	0.00123	0.00884	CcSEcCtD
Ticlopidine—MPO—epithelium—uterine cancer	0.00121	0.0416	CbGeAlD
Ticlopidine—Abdominal distension—Progesterone—uterine cancer	0.00119	0.00854	CcSEcCtD
Ticlopidine—Sepsis—Dactinomycin—uterine cancer	0.00115	0.00829	CcSEcCtD
Ticlopidine—MPO—renal system—uterine cancer	0.00112	0.0386	CbGeAlD
Ticlopidine—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00801	CcSEcCtD
Ticlopidine—Myositis—Epirubicin—uterine cancer	0.0011	0.0079	CcSEcCtD
Ticlopidine—Pain—Carboplatin—uterine cancer	0.00109	0.00785	CcSEcCtD
Ticlopidine—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00774	CcSEcCtD
Ticlopidine—Hepatic failure—Dactinomycin—uterine cancer	0.00107	0.00772	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Progesterone—uterine cancer	0.00103	0.00741	CcSEcCtD
Ticlopidine—Myositis—Doxorubicin—uterine cancer	0.00102	0.00731	CcSEcCtD
Ticlopidine—Body temperature increased—Carboplatin—uterine cancer	0.00101	0.00726	CcSEcCtD
Ticlopidine—Haemoglobin—Progesterone—uterine cancer	0.00095	0.00682	CcSEcCtD
Ticlopidine—Haemorrhage—Progesterone—uterine cancer	0.000945	0.00679	CcSEcCtD
Ticlopidine—Hepatitis—Progesterone—uterine cancer	0.000945	0.00679	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00672	CcSEcCtD
Ticlopidine—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.0009	0.00646	CcSEcCtD
Ticlopidine—Erythema multiforme—Progesterone—uterine cancer	0.000894	0.00642	CcSEcCtD
Ticlopidine—Liver function test abnormal—Dactinomycin—uterine cancer	0.000892	0.0064	CcSEcCtD
Ticlopidine—Tinnitus—Progesterone—uterine cancer	0.000881	0.00633	CcSEcCtD
Ticlopidine—Thrombocytosis—Epirubicin—uterine cancer	0.000868	0.00623	CcSEcCtD
Ticlopidine—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000861	0.00618	CcSEcCtD
Ticlopidine—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000857	0.00615	CcSEcCtD
Ticlopidine—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000857	0.00615	CcSEcCtD
Ticlopidine—Sepsis—Etoposide—uterine cancer	0.000836	0.006	CcSEcCtD
Ticlopidine—Flatulence—Progesterone—uterine cancer	0.000811	0.00582	CcSEcCtD
Ticlopidine—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00081	0.00582	CcSEcCtD
Ticlopidine—Thrombocytosis—Doxorubicin—uterine cancer	0.000803	0.00577	CcSEcCtD
Ticlopidine—Bone marrow depression—Epirubicin—uterine cancer	0.0008	0.00574	CcSEcCtD
Ticlopidine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.000799	0.00574	CcSEcCtD
Ticlopidine—Pancytopenia—Dactinomycin—uterine cancer	0.000793	0.00569	CcSEcCtD
Ticlopidine—Muscle spasms—Progesterone—uterine cancer	0.000791	0.00568	CcSEcCtD
Ticlopidine—Lung disorder—Epirubicin—uterine cancer	0.000763	0.00548	CcSEcCtD
Ticlopidine—Angioedema—Progesterone—uterine cancer	0.000752	0.0054	CcSEcCtD
Ticlopidine—Bone marrow depression—Doxorubicin—uterine cancer	0.00074	0.00531	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.000738	0.0053	CcSEcCtD
Ticlopidine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000735	0.00528	CcSEcCtD
Ticlopidine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000717	0.00515	CcSEcCtD
Ticlopidine—Lung disorder—Doxorubicin—uterine cancer	0.000706	0.00507	CcSEcCtD
Ticlopidine—Arthralgia—Progesterone—uterine cancer	0.000701	0.00503	CcSEcCtD
Ticlopidine—Myalgia—Progesterone—uterine cancer	0.000701	0.00503	CcSEcCtD
Ticlopidine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000681	0.00489	CcSEcCtD
Ticlopidine—Anaphylactic shock—Progesterone—uterine cancer	0.000672	0.00482	CcSEcCtD
Ticlopidine—Hepatitis—Dactinomycin—uterine cancer	0.000668	0.0048	CcSEcCtD
Ticlopidine—CYP2C8—renal system—uterine cancer	0.000655	0.0226	CbGeAlD
Ticlopidine—CYP1A1—epithelium—uterine cancer	0.000652	0.0225	CbGeAlD
Ticlopidine—CYP1A1—uterine cervix—uterine cancer	0.000646	0.0223	CbGeAlD
Ticlopidine—Anorexia—Progesterone—uterine cancer	0.00064	0.0046	CcSEcCtD
Ticlopidine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000635	0.00456	CcSEcCtD
Ticlopidine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000635	0.00456	CcSEcCtD
Ticlopidine—CYP2C8—endometrium—uterine cancer	0.000633	0.0218	CbGeAlD
Ticlopidine—Erythema multiforme—Dactinomycin—uterine cancer	0.000632	0.00454	CcSEcCtD
Ticlopidine—Cramp muscle—Etoposide—uterine cancer	0.000629	0.00452	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Epirubicin—uterine cancer	0.000614	0.00441	CcSEcCtD
Ticlopidine—CYP1A2—renal system—uterine cancer	0.000613	0.0211	CbGeAlD
Ticlopidine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000612	0.00439	CcSEcCtD
Ticlopidine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000609	0.00437	CcSEcCtD
Ticlopidine—CYP1A1—renal system—uterine cancer	0.000605	0.0209	CbGeAlD
Ticlopidine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000596	0.00428	CcSEcCtD
Ticlopidine—Arthropathy—Epirubicin—uterine cancer	0.000594	0.00426	CcSEcCtD
Ticlopidine—Dyspepsia—Progesterone—uterine cancer	0.000591	0.00425	CcSEcCtD
Ticlopidine—CYP2B6—renal system—uterine cancer	0.000588	0.0203	CbGeAlD
Ticlopidine—Decreased appetite—Progesterone—uterine cancer	0.000584	0.00419	CcSEcCtD
Ticlopidine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00058	0.00417	CcSEcCtD
Ticlopidine—Pain—Progesterone—uterine cancer	0.000574	0.00412	CcSEcCtD
Ticlopidine—Pancytopenia—Etoposide—uterine cancer	0.000574	0.00412	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000568	0.00408	CcSEcCtD
Ticlopidine—CYP1A1—mammalian vulva—uterine cancer	0.000565	0.0195	CbGeAlD
Ticlopidine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000554	0.00398	CcSEcCtD
Ticlopidine—CYP2E1—renal system—uterine cancer	0.000551	0.019	CbGeAlD
Ticlopidine—Arthropathy—Doxorubicin—uterine cancer	0.000549	0.00394	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Progesterone—uterine cancer	0.000549	0.00394	CcSEcCtD
Ticlopidine—CYP2C19—vagina—uterine cancer	0.000544	0.0188	CbGeAlD
Ticlopidine—CYP1A1—uterus—uterine cancer	0.000539	0.0186	CbGeAlD
Ticlopidine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000536	0.00385	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000534	0.00384	CcSEcCtD
Ticlopidine—Urticaria—Progesterone—uterine cancer	0.000533	0.00383	CcSEcCtD
Ticlopidine—Body temperature increased—Progesterone—uterine cancer	0.000531	0.00381	CcSEcCtD
Ticlopidine—Renal failure—Etoposide—uterine cancer	0.000529	0.0038	CcSEcCtD
Ticlopidine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000529	0.0038	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Etoposide—uterine cancer	0.000528	0.00379	CcSEcCtD
Ticlopidine—CYP2C8—female reproductive system—uterine cancer	0.000525	0.0181	CbGeAlD
Ticlopidine—MPO—lymph node—uterine cancer	0.000525	0.0181	CbGeAlD
Ticlopidine—Colitis—Epirubicin—uterine cancer	0.000518	0.00372	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000498	0.00357	CcSEcCtD
Ticlopidine—Myalgia—Dactinomycin—uterine cancer	0.000495	0.00356	CcSEcCtD
Ticlopidine—Hypersensitivity—Progesterone—uterine cancer	0.000495	0.00355	CcSEcCtD
Ticlopidine—Ecchymosis—Epirubicin—uterine cancer	0.000488	0.0035	CcSEcCtD
Ticlopidine—CYP1A1—female reproductive system—uterine cancer	0.000484	0.0167	CbGeAlD
Ticlopidine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000483	0.00347	CcSEcCtD
Ticlopidine—Asthenia—Progesterone—uterine cancer	0.000482	0.00346	CcSEcCtD
Ticlopidine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000481	0.00345	CcSEcCtD
Ticlopidine—Colitis—Doxorubicin—uterine cancer	0.000479	0.00344	CcSEcCtD
Ticlopidine—Pruritus—Progesterone—uterine cancer	0.000475	0.00341	CcSEcCtD
Ticlopidine—CYP2C8—vagina—uterine cancer	0.000474	0.0164	CbGeAlD
Ticlopidine—CYP2B6—female reproductive system—uterine cancer	0.000471	0.0162	CbGeAlD
Ticlopidine—Sepsis—Epirubicin—uterine cancer	0.000468	0.00336	CcSEcCtD
Ticlopidine—CYP2C9—female reproductive system—uterine cancer	0.000466	0.0161	CbGeAlD
Ticlopidine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000465	0.00334	CcSEcCtD
Ticlopidine—Diarrhoea—Progesterone—uterine cancer	0.000459	0.0033	CcSEcCtD
Ticlopidine—Erythema multiforme—Etoposide—uterine cancer	0.000457	0.00328	CcSEcCtD
Ticlopidine—Anorexia—Dactinomycin—uterine cancer	0.000452	0.00325	CcSEcCtD
Ticlopidine—Ecchymosis—Doxorubicin—uterine cancer	0.000452	0.00324	CcSEcCtD
Ticlopidine—Diabetes mellitus—Epirubicin—uterine cancer	0.00045	0.00323	CcSEcCtD
Ticlopidine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000448	0.00322	CcSEcCtD
Ticlopidine—Dizziness—Progesterone—uterine cancer	0.000444	0.00319	CcSEcCtD
Ticlopidine—CYP3A4—renal system—uterine cancer	0.000444	0.0153	CbGeAlD
Ticlopidine—CYP2E1—female reproductive system—uterine cancer	0.000442	0.0152	CbGeAlD
Ticlopidine—CYP1A1—female gonad—uterine cancer	0.000441	0.0152	CbGeAlD
Ticlopidine—Vascular purpura—Epirubicin—uterine cancer	0.000438	0.00315	CcSEcCtD
Ticlopidine—CYP1A1—vagina—uterine cancer	0.000438	0.0151	CbGeAlD
Ticlopidine—CYP2D6—renal system—uterine cancer	0.000437	0.0151	CbGeAlD
Ticlopidine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000437	0.00314	CcSEcCtD
Ticlopidine—Hepatic failure—Epirubicin—uterine cancer	0.000436	0.00313	CcSEcCtD
Ticlopidine—Sepsis—Doxorubicin—uterine cancer	0.000433	0.00311	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000432	0.00311	CcSEcCtD
Ticlopidine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000431	0.00309	CcSEcCtD
Ticlopidine—Vomiting—Progesterone—uterine cancer	0.000427	0.00307	CcSEcCtD
Ticlopidine—CYP2B6—vagina—uterine cancer	0.000426	0.0147	CbGeAlD
Ticlopidine—Rash—Progesterone—uterine cancer	0.000423	0.00304	CcSEcCtD
Ticlopidine—Dermatitis—Progesterone—uterine cancer	0.000423	0.00304	CcSEcCtD
Ticlopidine—Headache—Progesterone—uterine cancer	0.000421	0.00302	CcSEcCtD
Ticlopidine—Diabetes mellitus—Doxorubicin—uterine cancer	0.000417	0.00299	CcSEcCtD
Ticlopidine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000416	0.00299	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000415	0.00298	CcSEcCtD
Ticlopidine—Decreased appetite—Dactinomycin—uterine cancer	0.000413	0.00296	CcSEcCtD
Ticlopidine—Purpura—Epirubicin—uterine cancer	0.000407	0.00292	CcSEcCtD
Ticlopidine—Pain—Dactinomycin—uterine cancer	0.000406	0.00291	CcSEcCtD
Ticlopidine—Vascular purpura—Doxorubicin—uterine cancer	0.000405	0.00291	CcSEcCtD
Ticlopidine—Muscle spasms—Etoposide—uterine cancer	0.000405	0.00291	CcSEcCtD
Ticlopidine—Hepatic failure—Doxorubicin—uterine cancer	0.000403	0.0029	CcSEcCtD
Ticlopidine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000402	0.00289	CcSEcCtD
Ticlopidine—Nausea—Progesterone—uterine cancer	0.000399	0.00286	CcSEcCtD
Ticlopidine—Hyponatraemia—Epirubicin—uterine cancer	0.000393	0.00283	CcSEcCtD
Ticlopidine—Osteoarthritis—Epirubicin—uterine cancer	0.000392	0.00281	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000392	0.00281	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000388	0.00279	CcSEcCtD
Ticlopidine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000387	0.00278	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000384	0.00276	CcSEcCtD
Ticlopidine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000384	0.00276	CcSEcCtD
Ticlopidine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000383	0.00275	CcSEcCtD
Ticlopidine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000381	0.00274	CcSEcCtD
Ticlopidine—Purpura—Doxorubicin—uterine cancer	0.000376	0.0027	CcSEcCtD
Ticlopidine—Body temperature increased—Dactinomycin—uterine cancer	0.000375	0.00269	CcSEcCtD
Ticlopidine—Hyponatraemia—Doxorubicin—uterine cancer	0.000364	0.00261	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000363	0.0026	CcSEcCtD
Ticlopidine—Osteoarthritis—Doxorubicin—uterine cancer	0.000363	0.0026	CcSEcCtD
Ticlopidine—Liver function test abnormal—Epirubicin—uterine cancer	0.000362	0.0026	CcSEcCtD
Ticlopidine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000361	0.0026	CcSEcCtD
Ticlopidine—CYP3A4—female reproductive system—uterine cancer	0.000355	0.0123	CbGeAlD
Ticlopidine—Hypersensitivity—Dactinomycin—uterine cancer	0.00035	0.00251	CcSEcCtD
Ticlopidine—CYP2D6—female reproductive system—uterine cancer	0.00035	0.0121	CbGeAlD
Ticlopidine—Anaphylactic shock—Etoposide—uterine cancer	0.000344	0.00247	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—uterine cancer	0.000341	0.00245	CcSEcCtD
Ticlopidine—Asthenia—Dactinomycin—uterine cancer	0.000341	0.00245	CcSEcCtD
Ticlopidine—Thrombocytopenia—Etoposide—uterine cancer	0.000336	0.00242	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—uterine cancer	0.000335	0.00241	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000335	0.0024	CcSEcCtD
Ticlopidine—Anorexia—Etoposide—uterine cancer	0.000327	0.00235	CcSEcCtD
Ticlopidine—Diarrhoea—Dactinomycin—uterine cancer	0.000325	0.00233	CcSEcCtD
Ticlopidine—Pancytopenia—Epirubicin—uterine cancer	0.000322	0.00231	CcSEcCtD
Ticlopidine—CYP2D6—female gonad—uterine cancer	0.000318	0.011	CbGeAlD
Ticlopidine—Abdominal distension—Doxorubicin—uterine cancer	0.000315	0.00227	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—uterine cancer	0.00031	0.00223	CcSEcCtD
Ticlopidine—Vomiting—Dactinomycin—uterine cancer	0.000302	0.00217	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000299	0.00215	CcSEcCtD
Ticlopidine—Rash—Dactinomycin—uterine cancer	0.000299	0.00215	CcSEcCtD
Ticlopidine—Decreased appetite—Etoposide—uterine cancer	0.000299	0.00214	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—uterine cancer	0.000298	0.00214	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—uterine cancer	0.000297	0.00213	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000296	0.00213	CcSEcCtD
Ticlopidine—Pain—Etoposide—uterine cancer	0.000294	0.00211	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—uterine cancer	0.000288	0.00207	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—uterine cancer	0.000285	0.00205	CcSEcCtD
Ticlopidine—CYP1A1—lymph node—uterine cancer	0.000283	0.00977	CbGeAlD
Ticlopidine—Nausea—Dactinomycin—uterine cancer	0.000282	0.00202	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Etoposide—uterine cancer	0.000281	0.00202	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000277	0.00199	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—uterine cancer	0.000275	0.00197	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000274	0.00197	CcSEcCtD
Ticlopidine—Urticaria—Etoposide—uterine cancer	0.000273	0.00196	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—uterine cancer	0.000272	0.00196	CcSEcCtD
Ticlopidine—Body temperature increased—Etoposide—uterine cancer	0.000272	0.00195	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—uterine cancer	0.000271	0.00195	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—uterine cancer	0.000271	0.00195	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—uterine cancer	0.000266	0.00191	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—uterine cancer	0.000264	0.00189	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—uterine cancer	0.000256	0.00184	CcSEcCtD
Ticlopidine—Hypersensitivity—Etoposide—uterine cancer	0.000253	0.00182	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—uterine cancer	0.000253	0.00181	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—uterine cancer	0.000252	0.00181	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—uterine cancer	0.000251	0.0018	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—uterine cancer	0.000251	0.0018	CcSEcCtD
Ticlopidine—Asthenia—Etoposide—uterine cancer	0.000246	0.00177	CcSEcCtD
Ticlopidine—Pruritus—Etoposide—uterine cancer	0.000243	0.00175	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—uterine cancer	0.000237	0.0017	CcSEcCtD
Ticlopidine—Diarrhoea—Etoposide—uterine cancer	0.000235	0.00169	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—uterine cancer	0.000234	0.00168	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—uterine cancer	0.000233	0.00167	CcSEcCtD
Ticlopidine—Dizziness—Etoposide—uterine cancer	0.000227	0.00163	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—uterine cancer	0.000227	0.00163	CcSEcCtD
Ticlopidine—Vomiting—Etoposide—uterine cancer	0.000218	0.00157	CcSEcCtD
Ticlopidine—Rash—Etoposide—uterine cancer	0.000217	0.00156	CcSEcCtD
Ticlopidine—Dermatitis—Etoposide—uterine cancer	0.000216	0.00155	CcSEcCtD
Ticlopidine—Headache—Etoposide—uterine cancer	0.000215	0.00155	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—uterine cancer	0.000215	0.00154	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—uterine cancer	0.00021	0.00151	CcSEcCtD
Ticlopidine—Nausea—Etoposide—uterine cancer	0.000204	0.00147	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—uterine cancer	0.000201	0.00144	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—uterine cancer	0.000201	0.00144	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—uterine cancer	0.000193	0.00138	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—uterine cancer	0.000189	0.00135	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—uterine cancer	0.000186	0.00133	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—uterine cancer	0.000186	0.00133	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—uterine cancer	0.000184	0.00132	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000178	0.00128	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000175	0.00126	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000174	0.00125	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—uterine cancer	0.00017	0.00122	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—uterine cancer	0.00017	0.00122	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—uterine cancer	0.000167	0.0012	CcSEcCtD
Ticlopidine—Pain—Epirubicin—uterine cancer	0.000165	0.00118	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000162	0.00117	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000157	0.00113	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—uterine cancer	0.000157	0.00113	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—uterine cancer	0.000155	0.00111	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—uterine cancer	0.000153	0.0011	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—uterine cancer	0.000152	0.00109	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—uterine cancer	0.000152	0.00109	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000146	0.00105	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—uterine cancer	0.000142	0.00102	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—uterine cancer	0.000142	0.00102	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—uterine cancer	0.000141	0.00101	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—uterine cancer	0.000138	0.000992	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—uterine cancer	0.000136	0.000978	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—uterine cancer	0.000132	0.000946	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—uterine cancer	0.000131	0.000943	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—uterine cancer	0.000128	0.000918	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—uterine cancer	0.000127	0.000914	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—uterine cancer	0.000126	0.000905	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—uterine cancer	0.000122	0.000879	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—uterine cancer	0.000122	0.000876	CcSEcCtD
Ticlopidine—Rash—Epirubicin—uterine cancer	0.000121	0.000872	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—uterine cancer	0.000121	0.000871	CcSEcCtD
Ticlopidine—Headache—Epirubicin—uterine cancer	0.000121	0.000866	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—uterine cancer	0.000118	0.000846	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—uterine cancer	0.000114	0.000821	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—uterine cancer	0.000113	0.000814	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—uterine cancer	0.000112	0.000807	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—uterine cancer	0.000112	0.000806	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—uterine cancer	0.000112	0.000802	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—uterine cancer	0.000106	0.00076	CcSEcCtD
Ticlopidine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	4.85e-05	0.00136	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	4.72e-05	0.00133	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	4.66e-05	0.00131	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKR1C3—uterine cancer	4.6e-05	0.00129	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	4.56e-05	0.00128	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	4.5e-05	0.00126	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PGR—uterine cancer	4.48e-05	0.00126	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.44e-05	0.00125	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.44e-05	0.00125	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.37e-05	0.00123	CbGpPWpGaD
Ticlopidine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	4.35e-05	0.00122	CbGpPWpGaD
Ticlopidine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	4.29e-05	0.00121	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—YWHAE—uterine cancer	4.28e-05	0.0012	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.25e-05	0.00119	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—EP300—uterine cancer	4.21e-05	0.00118	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—FBXW7—uterine cancer	4.1e-05	0.00115	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4.01e-05	0.00113	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.01e-05	0.00113	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—VEGFA—uterine cancer	3.99e-05	0.00112	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—SRD5A2—uterine cancer	3.97e-05	0.00112	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NDUFB11—uterine cancer	3.97e-05	0.00112	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—NRAS—uterine cancer	3.94e-05	0.00111	CbGpPWpGaD
Ticlopidine—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	3.89e-05	0.00109	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—SRD5A2—uterine cancer	3.89e-05	0.00109	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NDUFB11—uterine cancer	3.89e-05	0.00109	CbGpPWpGaD
Ticlopidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	3.81e-05	0.00107	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.8e-05	0.00107	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.8e-05	0.00107	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NDUFB11—uterine cancer	3.67e-05	0.00103	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—SRD5A2—uterine cancer	3.67e-05	0.00103	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STK11—uterine cancer	3.58e-05	0.00101	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.58e-05	0.001	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CCL2—uterine cancer	3.57e-05	0.001	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.56e-05	0.001	CbGpPWpGaD
Ticlopidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	3.41e-05	0.000958	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—KRAS—uterine cancer	3.39e-05	0.000953	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.36e-05	0.000945	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.36e-05	0.000944	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.36e-05	0.000944	CbGpPWpGaD
Ticlopidine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.36e-05	0.000943	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SOCS3—uterine cancer	3.36e-05	0.000943	CbGpPWpGaD
Ticlopidine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.31e-05	0.00093	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.27e-05	0.000917	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.26e-05	0.000916	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CDKN2B—uterine cancer	3.21e-05	0.000902	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IGF1R—uterine cancer	3.12e-05	0.000876	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—PIK3CA—uterine cancer	3.12e-05	0.000876	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—CXCL8—uterine cancer	3.11e-05	0.000872	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.08e-05	0.000866	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—TP53—uterine cancer	3.02e-05	0.000847	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NDUFB11—uterine cancer	3e-05	0.000843	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—SRD5A2—uterine cancer	3e-05	0.000843	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—SMAD3—uterine cancer	2.93e-05	0.000824	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.91e-05	0.000819	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—HRAS—uterine cancer	2.88e-05	0.00081	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKR1B1—uterine cancer	2.87e-05	0.000806	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—STAR—uterine cancer	2.87e-05	0.000806	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—CXCL8—uterine cancer	2.82e-05	0.000792	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKR1B1—uterine cancer	2.81e-05	0.00079	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—STAR—uterine cancer	2.81e-05	0.00079	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—FGFR2—uterine cancer	2.8e-05	0.000786	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.79e-05	0.000783	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.76e-05	0.000775	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.76e-05	0.000775	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.75e-05	0.000773	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.74e-05	0.000769	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.74e-05	0.000769	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.66e-05	0.000747	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKR1B1—uterine cancer	2.65e-05	0.000745	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—STAR—uterine cancer	2.65e-05	0.000745	CbGpPWpGaD
Ticlopidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	2.62e-05	0.000737	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.62e-05	0.000736	CbGpPWpGaD
Ticlopidine—P2RY12—Hemostasis—AKT1—uterine cancer	2.55e-05	0.000715	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.51e-05	0.000705	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.43e-05	0.000683	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—STAR—uterine cancer	2.43e-05	0.000683	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.4e-05	0.000675	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ESR1—uterine cancer	2.39e-05	0.000672	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.34e-05	0.000657	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.34e-05	0.000657	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.27e-05	0.000638	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—NRAS—uterine cancer	2.26e-05	0.000636	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—POLD1—uterine cancer	2.25e-05	0.000633	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—POLD1—uterine cancer	2.21e-05	0.00062	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—STAR—uterine cancer	2.17e-05	0.000609	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.17e-05	0.000609	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.14e-05	0.000602	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.14e-05	0.000602	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CCL2—uterine cancer	2.11e-05	0.000592	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKR1C1—uterine cancer	2.11e-05	0.000592	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—POLD1—uterine cancer	2.08e-05	0.000584	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKR1C1—uterine cancer	2.06e-05	0.00058	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—STAR—uterine cancer	2e-05	0.00056	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKR1B1—uterine cancer	2e-05	0.00056	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.98e-05	0.000556	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—STAR—uterine cancer	1.98e-05	0.000556	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—PIK3CA—uterine cancer	1.97e-05	0.000553	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.96e-05	0.000549	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—KRAS—uterine cancer	1.95e-05	0.000547	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.95e-05	0.000547	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—POLD1—uterine cancer	1.91e-05	0.000536	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—RRM2—uterine cancer	1.88e-05	0.000528	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—RRM2—uterine cancer	1.84e-05	0.000517	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—DCN—uterine cancer	1.82e-05	0.000512	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.8e-05	0.000507	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.8e-05	0.000507	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—PIK3CA—uterine cancer	1.79e-05	0.000503	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—DCN—uterine cancer	1.79e-05	0.000502	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.78e-05	0.000501	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—ERBB2—uterine cancer	1.76e-05	0.000493	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—RRM2—uterine cancer	1.73e-05	0.000487	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.72e-05	0.000483	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—POLD1—uterine cancer	1.7e-05	0.000478	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—STAR—uterine cancer	1.69e-05	0.000475	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.69e-05	0.000475	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—DCN—uterine cancer	1.68e-05	0.000473	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.68e-05	0.000473	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.67e-05	0.000469	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CXCL8—uterine cancer	1.67e-05	0.000468	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—HRAS—uterine cancer	1.66e-05	0.000465	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CDKN1B—uterine cancer	1.63e-05	0.000457	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.62e-05	0.000456	CbGpPWpGaD
Ticlopidine—P2RY12—GPCR downstream signaling—AKT1—uterine cancer	1.61e-05	0.000452	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.59e-05	0.000447	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—RRM2—uterine cancer	1.59e-05	0.000447	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.59e-05	0.000446	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.59e-05	0.000446	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—POLD1—uterine cancer	1.57e-05	0.00044	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—POLD1—uterine cancer	1.55e-05	0.000436	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—DCN—uterine cancer	1.54e-05	0.000434	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CTNNB1—uterine cancer	1.54e-05	0.000432	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTEN—uterine cancer	1.5e-05	0.000421	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.5e-05	0.000421	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.46e-05	0.000411	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—AKT1—uterine cancer	1.46e-05	0.000411	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.45e-05	0.000408	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.45e-05	0.000408	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EP300—uterine cancer	1.43e-05	0.000401	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—RRM2—uterine cancer	1.42e-05	0.000399	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—DCN—uterine cancer	1.38e-05	0.000387	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.37e-05	0.000386	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VEGFA—uterine cancer	1.35e-05	0.00038	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NRAS—uterine cancer	1.34e-05	0.000375	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—POLD1—uterine cancer	1.33e-05	0.000373	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—RRM2—uterine cancer	1.31e-05	0.000367	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.3e-05	0.000366	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—STAR—uterine cancer	1.3e-05	0.000366	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.3e-05	0.000365	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—RRM2—uterine cancer	1.29e-05	0.000363	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—DCN—uterine cancer	1.27e-05	0.000356	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—STK11—uterine cancer	1.26e-05	0.000355	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.26e-05	0.000355	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—DCN—uterine cancer	1.26e-05	0.000353	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.24e-05	0.000349	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—STK11—uterine cancer	1.24e-05	0.000348	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.24e-05	0.000348	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.23e-05	0.000344	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.19e-05	0.000335	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.18e-05	0.000332	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—STK11—uterine cancer	1.17e-05	0.000328	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.17e-05	0.000328	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KRAS—uterine cancer	1.15e-05	0.000323	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.13e-05	0.000317	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.12e-05	0.000314	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—RRM2—uterine cancer	1.11e-05	0.000311	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.1e-05	0.000308	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—DCN—uterine cancer	1.07e-05	0.000302	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.07e-05	0.000301	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—STK11—uterine cancer	1.07e-05	0.000301	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CA—uterine cancer	1.06e-05	0.000297	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.04e-05	0.000293	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—POLD1—uterine cancer	1.02e-05	0.000288	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—uterine cancer	1.02e-05	0.000287	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.01e-05	0.000284	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1e-05	0.000282	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—uterine cancer	9.78e-06	0.000275	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.58e-06	0.000269	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKR1C1—uterine cancer	9.58e-06	0.000269	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKR1C3—uterine cancer	9.55e-06	0.000268	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—STK11—uterine cancer	9.55e-06	0.000268	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP19A1—uterine cancer	9.55e-06	0.000268	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—MTHFR—uterine cancer	9.5e-06	0.000267	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—MTHFR—uterine cancer	9.3e-06	0.000261	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.97e-06	0.000252	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—STK11—uterine cancer	8.78e-06	0.000247	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP19A1—uterine cancer	8.78e-06	0.000247	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—MTHFR—uterine cancer	8.77e-06	0.000246	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—STK11—uterine cancer	8.71e-06	0.000245	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP19A1—uterine cancer	8.71e-06	0.000245	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—uterine cancer	8.63e-06	0.000243	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.55e-06	0.00024	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—RRM2—uterine cancer	8.54e-06	0.00024	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—DCN—uterine cancer	8.29e-06	0.000233	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.17e-06	0.00023	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—MTHFR—uterine cancer	8.04e-06	0.000226	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP11A1—uterine cancer	7.81e-06	0.000219	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.8e-06	0.000219	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.73e-06	0.000217	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—STK11—uterine cancer	7.44e-06	0.000209	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP19A1—uterine cancer	7.44e-06	0.000209	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.37e-06	0.000207	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—MTHFR—uterine cancer	7.18e-06	0.000202	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.09e-06	0.000199	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.99e-06	0.000196	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.66e-06	0.000187	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—MTHFR—uterine cancer	6.6e-06	0.000185	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—MTHFR—uterine cancer	6.54e-06	0.000184	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.32e-06	0.000178	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.77e-06	0.000162	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP19A1—uterine cancer	5.74e-06	0.000161	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—STK11—uterine cancer	5.74e-06	0.000161	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—MTHFR—uterine cancer	5.59e-06	0.000157	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—uterine cancer	5.28e-06	0.000148	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—uterine cancer	5.18e-06	0.000145	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—EP300—uterine cancer	5.04e-06	0.000142	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—EP300—uterine cancer	4.94e-06	0.000139	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.93e-06	0.000138	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—uterine cancer	4.88e-06	0.000137	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—EP300—uterine cancer	4.65e-06	0.000131	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—uterine cancer	4.47e-06	0.000126	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTHFR—uterine cancer	4.32e-06	0.000121	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—EP300—uterine cancer	4.27e-06	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—uterine cancer	3.99e-06	0.000112	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—EP300—uterine cancer	3.81e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—uterine cancer	3.73e-06	0.000105	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—uterine cancer	3.67e-06	0.000103	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—uterine cancer	3.65e-06	0.000103	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—uterine cancer	3.64e-06	0.000102	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—EP300—uterine cancer	3.5e-06	9.84e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—EP300—uterine cancer	3.47e-06	9.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—uterine cancer	3.44e-06	9.67e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.16e-06	8.86e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—uterine cancer	3.11e-06	8.74e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—uterine cancer	3.04e-06	8.55e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—uterine cancer	2.98e-06	8.38e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—EP300—uterine cancer	2.97e-06	8.33e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.82e-06	7.91e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—uterine cancer	2.81e-06	7.9e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.59e-06	7.28e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—uterine cancer	2.58e-06	7.24e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.57e-06	7.21e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—uterine cancer	2.4e-06	6.74e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—uterine cancer	2.3e-06	6.46e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—EP300—uterine cancer	2.29e-06	6.43e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.19e-06	6.16e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—uterine cancer	2.12e-06	5.94e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—uterine cancer	2.1e-06	5.89e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—uterine cancer	1.79e-06	5.04e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.69e-06	4.76e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—uterine cancer	1.38e-06	3.89e-05	CbGpPWpGaD
